Company: BFRG
Filing Date: 2025-05-13
Form Type: 10-Q
Source: 0001641172-25-009946
Chunk: 29

Company: BullFrog AI Holdings, Inc.
Filing Date: 2025-05-13
Form: 10-Q
Item: Item 1
Chunk 29
---
 we may take in the future, will be sufficient to remediate
the material weaknesses we have identified or avoid potential future material weaknesses. Accordingly, there could continue to be a reasonable
possibility that a material misstatement of our financial statements would not be prevented or detected on a timely basis.

Changes
in Internal Control Over Financial Reporting

Other
than the material weakness remediation efforts described above, there has been no change in the Company’s internal control over
financial reporting during the Company’s most recent quarter that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial reporting.

20

PART
II. OTHER INFORMATION

 Item 1 Legal Proceedings.

To
our best knowledge, we are currently not a party to any legal proceedings that, individually or in the aggregate, are deemed to be material
to our financial condition or results of operations.

 Item 1A Risk Factors.

Smaller
reporting companies are not required to provide the information required by this item.

 Item 2 Unregistered Sales of Equity Securities and Use of Proceeds.

There
were no unregistered sales of equity securities during the three months ended March 31, 2025.

 Item 3 Defaults Upon Senior Securities.

None.

 Item 4 Mine Safety Disclosures.

Not
applicable.

 Item 5 Other Information.

(c)
Insider Trading Arrangements

During
the quarter ended March 31, 2025, none of the Company’s directors or executive officers adopted, modified or terminated any contract,
instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions
of Rule 10b5-1(c) or any “non-Rule 10b5-1 trading arrangement.” As previously disclosed, in June 2023, Vininder Singh, the
Chief Executive Officer and a Director of the Company, entered into a 10b5-1 sales plan (the “10b-5 Sales Plan”) intended
to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The 10b5 Sales Plan provides for the sale of up to 1,000,000
shares of common stock and will remain in effect until the earlier of (1) August 31, 2025; or (2) the date on which an aggregate of 1,000,000
shares of common stock have been sold under the 10b5 Sales Plan. Pursuant to the 10